IPO Plus

₹389.95

▼ -1.45 -0.37%

As of 04 Nov 2026 · delayed

NSE Listed · Healthcare

FDC Limited (FDC)

Volume: 2,38,39452W Range:₹312.95₹442
Market Cap₹6,349 Cr
Current Price₹389.95
Previous Close₹391.4
High / Low (52w)₹442 / ₹312.95
Volume2,38,394
Avg Vol (1W)—
Avg Vol (1M)—
Stock P/E20.27
Book Value₹163.75
Dividend Yield2.55%
ROE12.28%
ROA6.6%
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)₹19.24
P/B2.38
Debt / Equity0.48
50 DMA₹348.93
200 DMA₹370.12
Day change-0.37%
Price Chart
₹389.95▼ 4.56% · 1Y
₹448₹32127.9L
2025-11-10
2026-11-04

20-day avg volume: 2.8L shares

Pros
  • Pays a dividend yield of 2.5%.
  • Company is almost debt-free.
Quarterly Results
MetricSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Mar 2025
Revenue₹572 Cr₹668 Cr₹585 Cr₹465 Cr₹473 Cr—
EBITDA₹82 Cr₹191 Cr₹156 Cr₹52 Cr₹54 Cr—
Net Profit₹49 Cr₹132 Cr₹103 Cr₹28 Cr₹28 Cr—
EPS1.018.146.351.741.75—
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,163 Cr₹2,103 Cr₹1,943 Cr₹1,778 Cr
EBITDA₹438 Cr₹415 Cr₹440 Cr₹300 Cr
Net Profit₹281 Cr₹267 Cr₹305 Cr₹194 Cr
EPS17.2916.3918.5811.67
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹2,919 Cr₹2,714 Cr₹2,468 Cr₹2,343 Cr—
Total Liabilities₹434 Cr₹433 Cr₹371 Cr₹362 Cr—
Equity₹2,485 Cr₹2,281 Cr₹2,097 Cr₹1,982 Cr—
Total Debt₹15 Cr₹21 Cr₹21 Cr₹28 Cr—
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹200 Cr₹318 Cr₹221 Cr₹155 Cr—
Investing₹-110 Cr₹-200 Cr₹-17 Cr₹11 Cr—
Financing₹-93 Cr₹-92 Cr₹-202 Cr₹-180 Cr—
Free Cash Flow₹14 Cr₹221 Cr₹127 Cr₹42 Cr—
Shareholding
Promoter 69.94% Institutions 7.43% Public 22.63%
About FDC Limited

Healthcare · Drug Manufacturers - Specialty & Generic

FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastroenterology, ophthalmology, anti-diabetics, cardiovascular care, respiratory care, gynaecology, dermatology, paediatrics, analgesics, vitamins, and nutritional health in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured oral rehydration solution powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zifi-0, Zocon, Mycoderm, Zathrin, Victofol, Cotaryl, Ziglim-M, Amodep-AT, MumMum 1, Victofol Injection, Simyl MCT, Victofol – C, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.

www.fdcindia.com ↗
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search

Telegram App